Loxo Oncology (LOXO) Reports Q1 Loss of $0.96/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/1/2026

1. INTC
2. AMZN
3. RDDT
4. PINS
5. COIN
6. FSLR
7. SYK
8. FND
9. DASH
10. GILD

Go back to Loxo Oncology (LOXO) Reports Q1 Loss of $0.96/Share

Loxo Oncology Announces First Quarter 2017 Financial Results

May 9, 2017 6:45 AM EDT

Larotrectinib Late-Breaking Oral Presentation at ASCO Annual Meeting on June 3, 2017

Company to Host ASCO Conference Call and Webcast on June 4, 2017

$244.3M in Cash, Cash Equivalents, and Investments Provide Runway to Mid-2019

STAMFORD, Conn., May 09, 2017 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq: LOXO), a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, today reported financial results for the first quarter ended March 31, 2017. Loxo Oncology will not be conducting a conference call in conjunction with this earnings release.

We... More